Actinium Pharmaceuticals Inc. (Delaware)
Organization details
- Legal name
- Actinium Pharmaceuticals Inc. (Delaware)
- Former names
- Cactus Ventures, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- New York
- Headquarters state / province
- New York
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ATNM
- Primary stock exchange
- NYSE American
Identifiers
- SEC CIK
- 0001388320
- EIN
- 88-0378336
Board of directors
-
Ajit Shetty · DirectorSince 2023
-
C. David Nicholson · DirectorSince 2023
-
Jeffrey W. Chell · DirectorSince 2023
-
June Sherie Almenoff · DirectorSince 2024
-
Richard I. Steinhart · DirectorSince 2023
-
Sandesh Seth · Director · Chief Executive OfficerSince 2023
Chief executives
Director election results
Annual meeting of November 26, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
80.3%
-
84.3%
Board connections
2 of this board's directors also sit on 3 other boards. 3 are in the same sector.
-
Atossa Therapeutics Inc. Same sectorvia Richard I. Steinhart
-
Avalo Therapeutics Inc. Same sectorvia June Sherie Almenoff
-
Tenax Therapeutics Inc. Same sectorvia June Sherie Almenoff
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 14, 2026 | David Matthew T Officer (Chief Financial Officer) | Grant or award | +250,000 | — | — |
| Sep 2, 2026 | Jeffrey W. Chell Director | Grant or award | +61,600 | — | — |
| Sep 2, 2026 | Richard I. Steinhart Director | Grant or award | +62,800 | — | — |
| Sep 2, 2026 | Sandesh Seth Director, Officer (Chief Executive Officer) | Grant or award | +753,600 | — | — |
| Sep 2, 2026 | June Sherie Almenoff Director | Grant or award | +18,000 | — | — |
| Sep 2, 2026 | Ajit Shetty Director | Grant or award | +61,600 | — | — |
| Sep 2, 2026 | C. David Nicholson Director | Grant or award | +62,800 | — | — |
| Sep 2, 2026 | Sandesh Seth Director, Officer (Chief Executive Officer) | Grant or award | +1,027,274 | — | — |
| Aug 18, 2025 | Sandesh Seth Director, Officer (Chief Executive Officer) | Shares withheld for tax | −120,900 | $1.71 | $206,739 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Actinium Pharmaceuticals Inc. (Delaware)
Who is the CEO of Actinium Pharmaceuticals Inc. (Delaware)?
Sandesh Seth is Actinium Pharmaceuticals Inc. (Delaware)'s Chief Executive Officer.
How many directors are on Actinium Pharmaceuticals Inc. (Delaware)'s board?
Actinium Pharmaceuticals Inc. (Delaware)'s board has 6 directors: Ajit Shetty, C. David Nicholson, Jeffrey W. Chell, June Sherie Almenoff, Richard I. Steinhart and Sandesh Seth.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="actinium-pharmaceuticals-inc-delaware"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.